Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 694.10
+19.95 (2.96%)
At close: Aug 21, 2026
NSE:NEPHROPLUS Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, NSE:NEPHROPLUS stock has a consensus rating of "Buy" and an average price target of ₹822.50. The average 1-year stock price forecast is 18.50% higher than the current stock price, while the lowest is ₹725.00 (+4.45%) and the highest is ₹1,000 (+44.07%).
Price Target: ₹822.50 (+18.50%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:NEPHROPLUS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 2 | 2 | 2 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
12.10B
from 9.99B
Increased by 21.14%
Revenue Next Year
14.37B
from 12.10B
Increased by 18.79%
EPS This Year
15.79
from 8.10
Increased by 94.91%
EPS Next Year
20.91
from 15.79
Increased by 32.43%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.